AVE5026, a new hemisynthetic ultra-low-molecular-weight heparin for the prevention of venous thromboembolism in patients after total knee replacement surgery--TREK: a dose-ranging study (Q46136654)
Jump to navigation
Jump to search
scientific article published on 24 January 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | AVE5026, a new hemisynthetic ultra-low-molecular-weight heparin for the prevention of venous thromboembolism in patients after total knee replacement surgery--TREK: a dose-ranging study |
scientific article published on 24 January 2009 |
Statements
1 reference
AVE5026, a new hemisynthetic ultra-low-molecular-weight heparin for the prevention of venous thromboembolism in patients after total knee replacement surgery--TREK: a dose-ranging study (English)
1 reference
M R Lassen
1 reference
O E Dahl
1 reference
P Mismetti
1 reference
D Destrée
1 reference
A G G Turpie
1 reference
24 January 2009
1 reference
7
1 reference
4
1 reference
566-572
1 reference
Identifiers
1 reference